Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Scaling-up recombinant plasmid DNA for clinical trial: current concern, solution and status.

Ismail R, Allaudin ZN, Lila MA.

Vaccine. 2012 Sep 7;30(41):5914-20. doi: 10.1016/j.vaccine.2012.02.061. Epub 2012 Mar 7. Review.

PMID:
22406276
[PubMed - indexed for MEDLINE]
Free Article
2.

Marker-free plasmids for gene therapeutic applications--lack of antibiotic resistance gene substantially improves the manufacturing process.

Mairhofer J, Cserjan-Puschmann M, Striedner G, Nöbauer K, Razzazi-Fazeli E, Grabherr R.

J Biotechnol. 2010 Apr 1;146(3):130-7. doi: 10.1016/j.jbiotec.2010.01.025. Epub 2010 Feb 6.

PMID:
20138928
[PubMed - indexed for MEDLINE]
3.

Biomedical application of plasmid DNA in gene therapy: a new challenge for chromatography.

Sousa F, Passarinha L, Queiroz JA.

Biotechnol Genet Eng Rev. 2010;26:83-116. Review.

PMID:
21415877
[PubMed - indexed for MEDLINE]
4.

Engineering of bacterial strains and vectors for the production of plasmid DNA.

Bower DM, Prather KL.

Appl Microbiol Biotechnol. 2009 Apr;82(5):805-13. doi: 10.1007/s00253-009-1889-8. Epub 2009 Feb 10. Review.

PMID:
19205691
[PubMed - indexed for MEDLINE]
5.

Optimization and delivery of plasmid DNA for vaccination.

Jechlinger W.

Expert Rev Vaccines. 2006 Dec;5(6):803-25. Review.

PMID:
17184219
[PubMed - indexed for MEDLINE]
6.

Technical and regulatory hurdles for DNA vaccines.

Donnelly J, Berry K, Ulmer JB.

Int J Parasitol. 2003 May;33(5-6):457-67. Review.

PMID:
12782047
[PubMed - indexed for MEDLINE]
7.

Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA.

Mairhofer J, Grabherr R.

Mol Biotechnol. 2008 Jun;39(2):97-104. doi: 10.1007/s12033-008-9046-7. Review.

PMID:
18327557
[PubMed - indexed for MEDLINE]
8.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
[PubMed - indexed for MEDLINE]
9.

Plasmid DNA production for therapeutic applications.

Lara AR, Ramírez OT, Wunderlich M.

Methods Mol Biol. 2012;824:271-303. doi: 10.1007/978-1-61779-433-9_14. Erratum in: Methods Mol Biol. 2012;824:E1. Wunderlich, Martin [added].

PMID:
22160904
[PubMed - indexed for MEDLINE]
10.

Evaluating metabolic stress and plasmid stability in plasmid DNA production by Escherichia coli.

Silva F, Queiroz JA, Domingues FC.

Biotechnol Adv. 2012 May-Jun;30(3):691-708. doi: 10.1016/j.biotechadv.2011.12.005. Epub 2012 Jan 5. Review.

PMID:
22244816
[PubMed - indexed for MEDLINE]
11.

Plasmid DNA manufacturing technology.

Carnes AE, Williams JA.

Recent Pat Biotechnol. 2007;1(2):151-66. Review.

PMID:
19075838
[PubMed - indexed for MEDLINE]
12.

Upstream processing of plasmid DNA for vaccine and gene therapy applications.

Tejeda-Mansir A, Montesinos RM.

Recent Pat Biotechnol. 2008;2(3):156-72. Review.

PMID:
19075863
[PubMed - indexed for MEDLINE]
13.

Manufacturing and quality control of plasmid-based gene expression systems.

Eastman EM, Durland RH.

Adv Drug Deliv Rev. 1998 Mar 2;30(1-3):33-48.

PMID:
10837600
[PubMed - as supplied by publisher]
14.

Production of plasmid DNA encoding human hepatocyte growth factor for gene therapy.

Zhang Q, Bi J, Xiao F, Duan H, Wu B, Wu Z.

Biotechnol Appl Biochem. 2008 Jan;49(Pt 1):11-6.

PMID:
17516916
[PubMed - indexed for MEDLINE]
15.

A pestivirus DNA vaccine based on a non-antibiotic resistance Escherichia coli essential gene marker.

El-Attar LM, Scott S, Goh S, Good L.

Vaccine. 2012 Feb 21;30(9):1702-9. doi: 10.1016/j.vaccine.2011.12.078. Epub 2011 Dec 31.

PMID:
22212129
[PubMed - indexed for MEDLINE]
16.

Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation.

Bråve A, Gudmundsdotter L, Sandström E, Haller BK, Hallengärd D, Maltais AK, King AD, Stout RR, Blomberg P, Höglund U, Hejdeman B, Biberfeld G, Wahren B.

Vaccine. 2010 Nov 29;28(51):8203-9. doi: 10.1016/j.vaccine.2010.08.108. Epub 2010 Oct 15.

PMID:
20951666
[PubMed - indexed for MEDLINE]
17.

Plasmid DNA fermentation strain and process-specific effects on vector yield, quality, and transgene expression.

Carnes AE, Luke JM, Vincent JM, Schukar A, Anderson S, Hodgson CP, Williams JA.

Biotechnol Bioeng. 2011 Feb;108(2):354-63. doi: 10.1002/bit.22936.

PMID:
20830679
[PubMed - indexed for MEDLINE]
18.

The univector plasmid-fusion system, a method for rapid construction of recombinant DNA without restriction enzymes.

Liu Q, Li MZ, Leibham D, Cortez D, Elledge SJ.

Curr Biol. 1998 Dec 3;8(24):1300-9.

PMID:
9843682
[PubMed - indexed for MEDLINE]
Free Article
19.

RNA: the new revolution in nucleic acid vaccines.

Geall AJ, Mandl CW, Ulmer JB.

Semin Immunol. 2013 Apr;25(2):152-9. doi: 10.1016/j.smim.2013.05.001. Epub 2013 Jun 2. Review.

PMID:
23735226
[PubMed - indexed for MEDLINE]
20.

GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial.

Quaak SG, van den Berg JH, Toebes M, Schumacher TN, Haanen JB, Beijnen JH, Nuijen B.

Eur J Pharm Biopharm. 2008 Oct;70(2):429-38. doi: 10.1016/j.ejpb.2008.05.002. Epub 2008 May 17.

PMID:
18606527
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk